1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsGenentech Ophthalmology Co-pay Program is sponsored by Genentech. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
# Home Page | Genentech Ophthalmology Co-pay Program Patients and Caregivers Site launch * **Program Details**expand_more * **Offering/Eligibility** * **Terms and Conditions** Enroll in the **Genentech Ophthalmology Co-pay Program** Eligible commercially insured patients pay as little as*: up to $15,000 per calendar year, for VABYSMO, SUSVIMO and LUCENTIS **per drug administration co-pay,†** up to $1,000 per calendar year: * Surgical procedure and refill co-pay for SUSVIMO * Injection co-pay for VABYSMO and LUCENTIS The final amount owed by patients may be as little as $0, but may vary depending on the patient's health insurance plan.
Eligible commercially insured patients who are prescribed a Genentech ophthalmology drug for an FDA-approved use can receive up to $15,000 in assistance annually for drug costs and/or up to $1,000 in assistance annually for administration costs. For more information, see full program Terms and Conditions. **Please note, patients switching from one Genentech Ophthalmology drug to another must apply for the new treatment.
** If you forgot your username, please call **(855) 218-5307** for assistance. If you forgot your password, please click here. Due to privacy policies, health care professionals or specialty pharmacies who do not have an account must call **(855) 218-5307** to create one.
**Questions about this program? ** 9 a. m.
–8 p. m. ET, Monday through Friday (except major holidays) For questions about Genentech Ophthalmology treatments, please call **(833) EYE-GENE** (833) 393-4363.
Your Privacy Choices Reject All Accept All The Global Privacy Signal that you have set in your devices browser has been recognized. * ### Your Privacy Choices #### Your Privacy Choices To exercise other rights as may be allowed by state laws, please complete the form found here Data Subject Request Form. - [x] checkbox label label - [x] checkbox label label - [x] checkbox label label - [x] checkbox label label
According to the current listing, eligibility includes: Have been prescribed a Genentech Ophthalmology treatment for an FDA-approved indication; 18 years of age or older; have commercial (private or non-governmental) insurance; not receiving assistance from any charitable or…. Confirm the full requirements in the official notice before applying.
The current listing shows up to $15,000 per calendar year for Lucentis co-pay, up to $1,000 per calendar year for injection co-pay costs. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Genentech Ophthalmology Co-pay Program is funded by Genentech. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program